Manulife Financial Corporation vs Twist Bioscience Corp — how do they compare? Manulife Financial Corporation trades at $43.84 (market cap $72.68B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Manulife Financial Corporation is far larger — about 9.4× Twist Bioscience Corp's market cap, and Manulife Financial Corporation pays a 3.1% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MFC | TWST | |
|---|---|---|
Market Cap | $72.68B | $7.72B |
Sector | Financials | Health |
52-Week High | $44.77 | $124.88 |
52-Week Low | $30.06 | $24.16 |
Enterprise Value | $67.84B | $7.65B |
Dividend Yield | 3.1% | — |
Trailing returns across standard periods
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →